ZA801603B - 5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)-amino)-1-hydroxyethyl)-2-hydroxybenzoic acid derivatives - Google Patents

5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)-amino)-1-hydroxyethyl)-2-hydroxybenzoic acid derivatives

Info

Publication number
ZA801603B
ZA801603B ZA00801603A ZA801603A ZA801603B ZA 801603 B ZA801603 B ZA 801603B ZA 00801603 A ZA00801603 A ZA 00801603A ZA 801603 A ZA801603 A ZA 801603A ZA 801603 B ZA801603 B ZA 801603B
Authority
ZA
South Africa
Prior art keywords
benzodioxan
ylmethyl
dihydro
hydroxyethyl
amino
Prior art date
Application number
ZA00801603A
Other languages
English (en)
Inventor
J Grisar
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of ZA801603B publication Critical patent/ZA801603B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
ZA00801603A 1979-05-04 1980-03-19 5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)-amino)-1-hydroxyethyl)-2-hydroxybenzoic acid derivatives ZA801603B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/036,243 US4206125A (en) 1979-05-04 1979-05-04 5-[2-[(2,3-Dihydro-1,4-benzodioxan-2-ylmethyl)amino]-1-hydroxyethyl]-2-hydroxybenzoic acid derivatives

Publications (1)

Publication Number Publication Date
ZA801603B true ZA801603B (en) 1981-03-25

Family

ID=21887496

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00801603A ZA801603B (en) 1979-05-04 1980-03-19 5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)-amino)-1-hydroxyethyl)-2-hydroxybenzoic acid derivatives

Country Status (21)

Country Link
US (1) US4206125A (xx)
JP (1) JPS55147274A (xx)
AT (1) AT369365B (xx)
AU (1) AU531739B2 (xx)
BE (1) BE883087A (xx)
CA (1) CA1148963A (xx)
CH (1) CH645372A5 (xx)
DE (1) DE3014738A1 (xx)
DK (1) DK154503C (xx)
ES (1) ES490814A0 (xx)
FR (1) FR2455598A1 (xx)
GB (1) GB2051780B (xx)
IE (1) IE49564B1 (xx)
IL (1) IL59681A (xx)
IT (1) IT1127441B (xx)
NL (1) NL8002208A (xx)
NO (1) NO153572C (xx)
NZ (1) NZ193236A (xx)
PH (1) PH15963A (xx)
SE (1) SE434745B (xx)
ZA (1) ZA801603B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003022A1 (en) * 1986-10-31 1988-05-05 Pfizer Inc. Relatively low molecular weight polypeptides as renin inhibitors
JP2931986B2 (ja) * 1989-02-17 1999-08-09 武田薬品工業株式会社 アラルキルアミン誘導体
AU2003298094A1 (en) * 2002-10-22 2004-05-13 Glaxo Group Limited Medicinal arylethanolamine compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054104A (xx) * 1962-07-20
US3514465A (en) * 1966-12-30 1970-05-26 Degussa Certain thiazolyl- and pyridinylaminoketones
US3883560A (en) * 1973-07-05 1975-05-13 Colgate Palmolive Co Salicylamidophenethanolamines
CA1147342A (en) * 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
JPS55124742A (en) * 1979-03-20 1980-09-26 Kyowa Hakko Kogyo Co Ltd Novel aminoalcohol derivative

Also Published As

Publication number Publication date
AU5707780A (en) 1980-11-06
DK193580A (da) 1980-11-05
FR2455598A1 (fr) 1980-11-28
NO801296L (no) 1980-11-05
IT8048373A0 (it) 1980-04-09
DK154503C (da) 1989-04-10
AU531739B2 (en) 1983-09-01
FR2455598B1 (xx) 1983-05-27
IE49564B1 (en) 1985-10-30
DE3014738C2 (xx) 1989-08-03
US4206125A (en) 1980-06-03
DE3014738A1 (de) 1980-11-13
IT1127441B (it) 1986-05-21
NO153572B (no) 1986-01-06
NL8002208A (nl) 1980-11-06
ES8104997A1 (es) 1981-05-16
CA1148963A (en) 1983-06-28
ES490814A0 (es) 1981-05-16
NZ193236A (en) 1982-09-14
GB2051780A (en) 1981-01-21
IE800572L (en) 1980-11-04
GB2051780B (en) 1982-12-22
ATA232780A (de) 1982-05-15
JPS642115B2 (xx) 1989-01-13
SE8003243L (sv) 1980-11-05
IL59681A (en) 1984-04-30
DK154503B (da) 1988-11-21
CH645372A5 (de) 1984-09-28
AT369365B (de) 1982-12-27
PH15963A (en) 1983-05-04
NO153572C (no) 1986-04-16
JPS55147274A (en) 1980-11-17
BE883087A (fr) 1980-09-01
SE434745B (sv) 1984-08-13
IL59681A0 (en) 1980-06-30

Similar Documents

Publication Publication Date Title
AU6103880A (en) 2,4,6-triiodoisophthalic acids
DK343980A (da) 2,4,6-triiod-isophthalsyrederivater
AU539519B2 (en) 7(2-(2-aminothiazol-4-yl)-2(2-carboxyprop-2-oxyimino) acteamido)-3-(1-pyridiniumethyl)ceph 3-em-4-carboxylate
AU535320B2 (en) 2-(2-(1,4-benzodioxanyl))-2-imidazoling derivatives
GB2045757B (en) 1,2,3-thiadiazole-5-carboxylic acid derivatives
IT1131682B (it) 2-(3,4,5-trimetossifenil)-tiazoli 4,5-bisostituiti e procedimento per la loro preparazione
ZA801603B (en) 5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)-amino)-1-hydroxyethyl)-2-hydroxybenzoic acid derivatives
BE880509A (fr) Procede de preparation de 2',6'-dialkyl-n-alcoxymethyl-2-chloro-acetanilides
IT1145435B (it) Procedimento per la produzione di 2,3-dimetilbutene-2
GB2020652B (en) 7(2-(w-1,3-dithiolan-2-imino)substituted)-acetylamino) cephalosporanic acid derivatives
IT1145279B (it) Procedimento per la produzione di 3-(4)-formiltriciclo(5,2,1,0,2,6)-decene-8
FI800106A (fi) Foerfarande foer separering av d,1 2-(6-metoxi-2-naftyl)propionsyra
AU565660B2 (en) N-(2-(1,2-dichlorovinyloxy)-phenylsulphonyl)-(thio)ureas
ES544201A0 (es) Procedimiento para preparar 2- (fenetil) -5- (3,4-metilen- dioxi)-x-hidroxibencil) -pirrolidina
AU534572B2 (en) 6b-(2-(2:-methylphenorgcarbonyl)-2-thien-3:-ylacetamido)
DE3067029D1 (en) Process for the preparation of 2,2'-imino-bis benzothiazole compounds
ES514937A0 (es) "procedimiento de preparar derivados del acido sulfamico y similares".
AU5865980A (en) Salts of herbicidal 1,2,4-thiadiazolyl-5-urea derivatives
FI782961A (fi) Foerfarande foer framstaellning av 2-(2',2',2'-tribrometyl)-4-klorcyklobutan-1-oner
AU525112B2 (en) 2-(2'2'2'-tribromomethyl)-4-chlorocyclobutan-1-ones
IL55897A0 (en) The preparation of 2-(2',2',2'-tribromoethyl)-4-chlorocyclobutan-1-ones
AR223654A1 (es) Procedimiento para la preparacion de 2-(2',2'2-tribromoetil)-4-clorociclobutan-1-onas
MX5875E (es) Procedimiento para la preparacion de 2-(2',2',2'-tribromoetil)-4-clorociclobutan-1-onas
GB2044753B (en) Derivatives of 1,4 - dihydropyridine - 3 - carbothiol acids
IT1126160B (it) Macchina formatrice d'anse